Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $8,100 | 4 | 80.3% |
| Food and Beverage | $1,096 | 39 | 10.9% |
| Travel and Lodging | $476.67 | 3 | 4.7% |
| Consulting Fee | $300.00 | 1 | 3.0% |
| Education | $114.90 | 4 | 1.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $8,380 | 8 | $0 (2022) |
| Medical Device Business Services, Inc. | $563.90 | 10 | $0 (2017) |
| CONMED Corporation | $317.20 | 2 | $0 (2019) |
| Clovis Oncology, Inc. | $194.28 | 14 | $0 (2020) |
| TESARO, Inc. | $190.20 | 4 | $0 (2019) |
| INTUITIVE SURGICAL, INC. | $129.27 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $106.94 | 5 | $0 (2024) |
| Janssen Scientific Affairs, LLC | $90.76 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $82.80 | 4 | $0 (2024) |
| Myriad Genetic Laboratories, Inc. | $19.74 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $199.20 | 4 | INTUITIVE SURGICAL, INC. ($129.27) |
| 2023 | $56.25 | 3 | GlaxoSmithKline, LLC. ($37.49) |
| 2022 | $1,088 | 3 | AstraZeneca Pharmaceuticals LP ($1,050) |
| 2021 | $7,291 | 5 | AstraZeneca Pharmaceuticals LP ($7,291) |
| 2020 | $76.25 | 4 | GlaxoSmithKline, LLC. ($31.59) |
| 2019 | $689.12 | 19 | CONMED Corporation ($300.00) |
| 2018 | $32.59 | 2 | CONMED Corporation ($17.20) |
| 2017 | $654.66 | 11 | Medical Device Business Services, Inc. ($563.90) |
All Payment Transactions
51 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/26/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $129.27 | General |
| Category: SURGERY | ||||||
| 07/24/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: ONCOLOGY | ||||||
| 05/16/2024 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: ONCOLOGY | ||||||
| 02/01/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $32.07 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $20.49 | General |
| Category: ONCOLOGY | ||||||
| 08/17/2023 | GlaxoSmithKline, LLC. | ZEJULA (Drug), JEMPERLI | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: ONCOLOGY | ||||||
| 05/18/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: ONCOLOGY | ||||||
| 09/15/2022 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $17.96 | General |
| Category: ONCOLOGY | ||||||
| 05/19/2022 | Myriad Genetic Laboratories, Inc. | myRisk (Device) | Food and Beverage | Cash or cash equivalent | $19.74 | General |
| Category: Germline DNA Sequencing Hereditary Cancer and Rearrangement Analysis | ||||||
| 03/07/2022 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,050.00 | General |
| Category: Oncology | ||||||
| 12/19/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $200.00 | General |
| Category: Oncology | ||||||
| 09/16/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,350.00 | General |
| Category: Oncology | ||||||
| 06/02/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,500.00 | General |
| Category: Oncology | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $116.48 | General |
| Category: Oncology | ||||||
| 10/15/2020 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $18.72 | General |
| Category: Oncology | ||||||
| 08/06/2020 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological), LYNPARZA | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: ONCOLOGY | ||||||
| 02/19/2020 | Cumberland Pharmaceuticals, Inc. | Caldolor (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: Anesthesiology (Pain Management) | ||||||
| 01/16/2020 | GlaxoSmithKline, LLC. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $31.59 | General |
| Category: ONCOLOGY | ||||||
| 12/05/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $3.87 | General |
| Category: Oncology | ||||||
| 11/22/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: ONCOLOGY | ||||||
| 11/21/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: Oncology | ||||||
| 11/07/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Oncology | ||||||
| 10/17/2019 | CONMED Corporation | — | Consulting Fee | Cash or cash equivalent | $300.00 | General |
| 09/19/2019 | Clovis Oncology, Inc. | Rubraca (Drug) | Education | In-kind items and services | $7.20 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 108 | 164 | $24,784 | $10,383 |
| 2022 | 6 | 133 | 197 | $46,723 | $21,755 |
| 2021 | 6 | 135 | 195 | $55,070 | $26,839 |
| 2020 | 4 | 90 | 145 | $16,894 | $8,785 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 92 | $14,576 | $5,094 | 34.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 19 | 19 | $4,370 | $2,217 | 50.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 15 | 20 | $3,660 | $1,823 | 49.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 12 | 33 | $2,178 | $1,250 | 57.4% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 11 | 11 | $20,419 | $8,084 | 39.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 82 | $10,168 | $5,139 | 50.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 16 | 16 | $5,040 | $2,556 | 50.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $5,060 | $2,540 | 50.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 15 | 20 | $3,000 | $2,044 | 68.1% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 11 | 46 | $3,036 | $1,392 | 45.8% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 13 | 13 | $24,956 | $9,592 | 38.4% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 16 | 36 | $7,335 | $4,950 | 67.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 23 | 23 | $7,245 | $4,040 | 55.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 40 | 54 | $6,518 | $3,508 | 53.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 28 | 28 | $6,310 | $3,496 | 55.4% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2021 | 15 | 41 | $2,706 | $1,255 | 46.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 17 | 17 | $5,355 | $2,856 | 53.3% |
| 99231 | Subsequent hospital inpatient care, typically 15 minutes per day | Facility | 2020 | 30 | 71 | $4,686 | $2,246 | 47.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 32 | 41 | $3,813 | $2,023 | 53.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 11 | 16 | $3,040 | $1,660 | 54.6% |
About Dr. Shannon Grabosch, M.D
Dr. Shannon Grabosch, M.D is a Gynecologic Oncology healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2010. The National Provider Identifier (NPI) number assigned to this provider is 1003136151.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Shannon Grabosch, M.D has received a total of $10,087 in payments from pharmaceutical and medical device companies, with $199.20 received in 2024. These payments were reported across 51 transactions from 11 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($8,100).
As a Medicare-enrolled provider, Grabosch has provided services to 466 Medicare beneficiaries, totaling 701 services with total Medicare billing of $67,762. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Student in an Organized Health Care Education/Training Program, Obstetrics & Gynecology
- Location Saint Louis, MO
- Active Since 06/10/2010
- Last Updated 01/14/2021
- Taxonomy Code 207VX0201X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1003136151
Products in Payments
- LYNPARZA (Drug) $8,380
- HARMONIC Product Family (Device) $563.90
- ZEJULA (Drug) $297.14
- Rubraca (Drug) $194.28
- Da Vinci Surgical System (Device) $129.27
- DARZALEX (Biological) $90.76
- KEYTRUDA (Biological) $82.80
- myRisk (Device) $19.74
- AirSeal (Device) $17.20
- Caldolor (Drug) $11.93
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Saint Louis
Dr. Matthew Powell, Md, MD
Gynecologic Oncology — Payments: $371,500
Dr. Premal Thaker, Md, MD
Gynecologic Oncology — Payments: $343,223
Dr. David Mutch, Md, MD
Gynecologic Oncology — Payments: $89,524
Dr. Carolyn Mccourt, Md, MD
Gynecologic Oncology — Payments: $34,327
Dan-Arin Silasi, Md, MD
Gynecologic Oncology — Payments: $27,564
Dr. Dineo Khabele, Md, MD
Gynecologic Oncology — Payments: $21,978